Related references
Note: Only part of the references are listed.Overexpression of BACH1 mediated by IGF2 facilitates hepatocellular carcinoma growth and metastasis via IGF1R and PTK2
Meng Xie et al.
THERANOSTICS (2022)
Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM+ and CD90+ Human Hepatocellular Carcinoma Cells in an Orthotopic Mouse Model
Mohamed Moustafa et al.
CANCERS (2022)
Caspase-3-induced activation of SREBP2 drives drug resistance via promotion of cholesterol biosynthesis in hepatocellular carcinoma
Etienne H. Mok et al.
CANCER RESEARCH (2022)
Co-administration of MDR1 and BCRP or EGFR/PI3K inhibitors overcomes lenvatinib resistance in hepatocellular carcinoma
Dawei Sun et al.
FRONTIERS IN ONCOLOGY (2022)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
BACH1 recruits NANOG and histone H3 lysine 4 methyltransferase MLL/SET1 complexes to regulate enhancer-promoter activity and maintains pluripotency
Cong Niu et al.
NUCLEIC ACIDS RESEARCH (2021)
A Novel Therapeutic Target, BACH1, Regulates Cancer Metabolism
Joselyn Padilla et al.
CELLS (2021)
EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma
Hoi-Wing Leung et al.
CANCER RESEARCH (2021)
Combination therapy for advanced hepatocellular carcinoma: do we see the light at the end of the tunnel?
Ti Zhang et al.
HEPATOBILIARY SURGERY AND NUTRITION (2021)
BTB and CNC homology 1 (Bach1) induces lung cancer stem cell phenotypes by stimulating CD44 expression
Pan Jiang et al.
RESPIRATORY RESEARCH (2021)
Insights into new mechanisms and models of cancer stem cell multidrug resistance
Y. Garcia-Mayea et al.
SEMINARS IN CANCER BIOLOGY (2020)
Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma
Tan Boon Toh et al.
JOURNAL OF HEPATOLOGY (2020)
BACH1 Promotes Pancreatic Cancer Metastasis by Repressing Epithelial Genes and Enhancing Epithelial-Mesenchymal Transition
Masaki Sato et al.
CANCER RESEARCH (2020)
CD73 sustained cancer-stem-cell traits by promoting SOX9 expression and stability in hepatocellular carcinoma
Xiao-Lu Ma et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Cross talk between oxidative stress and hypoxia via thioredoxin and HIF-2α drives metastasis of hepatocellular carcinoma
Man-Qing Cao et al.
FASEB JOURNAL (2020)
LncRNA TRG-AS1 stimulates hepatocellular carcinoma progression by sponging miR-4500 to modulate BACH1
Xuehu Sun et al.
CANCER CELL INTERNATIONAL (2020)
BTB and CNC homology 1 (Bach1) promotes human ovarian cancer cell metastasis by HMGA2-mediated epithelial-mesenchymal transition
Wenyan Han et al.
CANCER LETTERS (2019)
Increased Thioredoxin-1 Expression Promotes Cancer Progression and Predicts Poor Prognosis in Patients with Gastric Cancer
Wenjing Shang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Bach1 regulates self-renewal and impedes mesendodermal differentiation of human embryonic stem cells
Xiangxiang Wei et al.
SCIENCE ADVANCES (2019)
Diverse compounds from pleuromutilin lead to a thioredoxin inhibitor and inducer of ferroptosis
Evijola Llabani et al.
NATURE CHEMISTRY (2019)
Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1
Luca Lignitto et al.
CELL (2019)
BACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis
Clotilde Wiel et al.
CELL (2019)
MicroRNA-1305 Inhibits the Stemness of LCSCs and Tumorigenesis by Repressing the UBE2T-Dependent Akt-Signaling Pathway
Xiaoyong Wei et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Thioredoxin Downregulation Enhances Sorafenib Effects in Hepatocarcinoma Cells
Maria Jose Lopez-Grueso et al.
ANTIOXIDANTS (2019)
Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling
Ming Luo et al.
CELL METABOLISM (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Quercetin suppresses breast cancer stem cells (CD44+/CD24-) by inhibiting the PI3K/Akt/mTOR-signaling pathway
Xiuli Li et al.
LIFE SCIENCES (2018)
Bach1: Function, Regulation, and Involvement in Disease
Xinyue Zhang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
CD133 confers cancer stem-like cell properties by stabilizing EGFR-AKT signaling in hepatocellular carcinoma
Jae-Woo Jang et al.
CANCER LETTERS (2017)
Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression
Isaac S. Harris et al.
CANCER CELL (2015)
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
Joong-Won Park et al.
LIVER INTERNATIONAL (2015)
PI3K/AKT signaling pathway and cancer: an updated review
Miriam Martini et al.
ANNALS OF MEDICINE (2014)
Heme and erythropoieis: more than a structural role
Deborah Chiabrando et al.
HAEMATOLOGICA (2014)
EXPRESSION OF THIOREDOXINS AND GLUTAREDOXINS IN HUMAN HEPATOCELLULAR CARCINOMA: CORRELATION TO CELL PROLIFERATION, TUMOR SIZE AND METABOLIC SYNDROME
A. Mollbrink et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2014)
Cancer stem cells in the development of liver cancer
Taro Yamashita et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
Jeffrey A. Magee et al.
CANCER CELL (2012)
A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination
Ramesh K. Ramanathan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Anti-oxidative, anti-cancer and anti-inflammatory actions by thioredoxin 1 and thioredoxin-binding protein-2
Rie Watanabe et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Thioredoxin and Cancer: A Role for Thioredoxin in all States of Tumor Oxygenation
Therese Christina Karlenius et al.
Cancers (2010)
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Maximilian Diehn et al.
NATURE (2009)
Increased expression of thioredoxin-1, vascular endothetial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancer
Terumasa Noike et al.
HUMAN PATHOLOGY (2008)
Heme induces ubiquitination and degradation of the transcription factor bach1
Yukari Zenke-Kawasaki et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Increased expression of specific thioredoxin family proteins; A pilot immunohistochemical study on human hepatocellular carcinoma
P. Cunnea et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2007)
The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma
AF Baker et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2006)
Dynamic cytoplasmic anchoring of the transcription factor Bach1 by intracellular hyaluronic acid binding protein IHABP
C Yamasaki et al.
JOURNAL OF BIOCHEMISTRY (2005)
Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity
EJ Meuillet et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2004)
Antioxidant Function of Thioredoxin and Glutaredoxin Systems
Arne Holmgren
ANTIOXIDANTS & REDOX SIGNALING (2000)
Share Paper
